Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the sellers of InnovDr in connection with the divestment to Doktor.se
Mandate

Vinge advises the sellers of InnovDr in connection with the divestment to Doktor.se

March 15, 2022 M&A

InnovDr is a digital provider of health and medical services. The business, which started in 2016, consists of Kollarna.se and the subareas urinkollen.se, aknekollen.se, borreliakollen.se, menskollen.se, ögonkollen.se and herpeskollen.se.

The owners of InnovDr divest the company to Doktor.se, which is one of the leading companies in digital care in Sweden.

Vinge’s team consisted of Wibeke Sorling, Jenny Sandlund, Hanna Jansson and Amanda Stoltz.

Related

Vinge is advising on the establishment of Ballista Capital

 Ballista Capital held its final closing on 9 June 2025. The investor base primarily comprises family offices and investors with strong ties to northern Sweden.
July 07, 2025

Vinge advises The Qt Company Ltd on its public offer for I.A.R. Systems Group AB (publ)

The Qt Company Ltd (“The Qt Company”), a wholly owned subsidiary of Qt Group Plc, has announced a public tender offer to the shareholders of I.A.R. Systems Group AB (publ) (“IAR”) to tender all class B shares in IAR to The Qt Company at a price of SEK 180 in cash per share
July 04, 2025

Vinge has advised Consolid on the establishment of Consolid Equity III

 The fund held its final closing on June 2, 2025, having secured commitments from a diverse investor base that includes several leading institutional investors from Europe and North America, as well as established fund-of-funds. The fundraising was highly successful, with the fund significantly oversubscribed. Consolid Equity III has more than doubled its total commitments compared to its predecessor fund.
July 02, 2025